Tanya Cranfield

Portsmouth, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Journal: Leukemia

Published: April 24, 2024

A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.

A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.

Journal: British journal of haematology

Published: April 25, 2023

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.

Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.

Journal: Blood

Published: May 13, 2022

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.

Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine: Comment from Doyle et al.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 14, 2021

Real-world experience with caplacizumab in the management of acute TTP.

Real-world experience with caplacizumab in the management of acute TTP.

Journal: Blood

Published: June 10, 2020

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Characterization and treatment of congenital thrombotic thrombocytopenic purpura.

Journal: Blood

Published: November 07, 2018

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

Journal: Blood

Published: December 23, 2016

Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.

Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.

Journal: British journal of haematology

Published: October 26, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026